Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Morris Gabriel S
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Rachman Ilya M
Immix Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(5.8%),Orin H(5.8%)
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hsu Jason
Immix Biopharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-CFO Morris Gabriel S
Immix Biopharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Rachman Ilya M
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hsu Jason
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Ng Carey
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Adams Helen C.
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hsu Jason
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director BUCHAN MELISSA JANE
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Marquet Magda
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Marquet Magda
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Marquet Magda
Immix Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Yekaterina Chudnovsky(19.99%),GKCC, LLC(19.99%)
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Chudnovsky Yekaterina
Immix Biopharma | 3: Initial statement of beneficial ownership of securities-Director Chudnovsky Yekaterina
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director BUCHAN MELISSA JANE
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-CFO Morris Gabriel S
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Rachman Ilya M
No Data